Top Markets
Coin of the day
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940
Rank in Stocks #519
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Share Price
$1,071.12
Market Cap
$49.58B
Change (1 day)
-3.73%
Change (1 year)
-5.56%
Country
KR
Trade Samsung Biologics Co.,Ltd. (207940)

Category

Stock split history for Samsung Biologics Co.,Ltd. (207940)
Samsung Biologics Co.,Ltd. stock (symbol: 207940) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 12, 2026.
One 207940 share bought prior to Aug 12, 2026 would equal to 0 207940 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
BE
1 x3
AU